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Abstract
The protozoan parasites Plasmodium, Leishmania, Trypanosoma, Entamoeba histo-
lytica, Giardia lamblia, and Trichomonas vaginalis, cause high morbidity and mortality
in developed and developing countries. P. falciparum is responsible for malaria, one of
the most severe infectious diseases in Africa. Hundreds of million people are affected by
Trypanosoma and Leishmania that cause African and South American trypanosomiasis,
and leishmaniasis. E. histolytica and G. lamblia contribute to the enormous burden of
diarrheal diseases worldwide; trichomoniasis is the most common nonviral sexually
transmitted disease in the world. Because of the important side effects of current treat-
ments and the decrease in drug susceptibility, there is a renewed interest for the search
of therapeutic alternatives against these pathogens. Natural products obtained from
medicinal plants and their derivatives have been recognized for many years as a source
of therapeutic agents. There are numerous reports about medicinal plants that are used
by indigenous communities to treat gastrointestinal complaints. Importantly, phyto-
chemical studies have allowed the identification of several secondary metabolites with
anti-parasite activity. Our review revealed that Mexican medicinal plants have a great
potential for the identification of new molecules with activity against protozoan para-
sites of medical importance worldwide and their potential use as new therapeutic
compounds.
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1. Introduction
Protozoan parasites represent a large public health problem worldwide, from tropical and
developing regions to developed countries. Among them, Plasmodium spp. that produces
malaria is considered as the first parasitic cause of death both in people living in endemic areas
and travelers returning from these regions, affecting 240 million people in 2009 and producing
more than 1 million deaths in children each year in Africa alone [1]. The hemoflagellates of the
Trypanosomatidae family, Leishmania spp. and Trypanosoma spp. are responsible for three major
human diseases, leishmaniasis (cutaneous, mucocutaneous, and visceral leishmaniasis),
sleeping sickness (African trypanosomiasis), and Chagas disease (American trypanosomiasis),
respectively [2]. Other highly prevalent infective parasites include the intestinal anaerobic
protozoa, Entamoeba histolytica and Giardia intestinalis (commonly referred to as G. lamblia or
G. duodenalis) that contribute to the enormous burden of diarrheal diseases worldwide, as well
as Trichomonas vaginalis, which is the most common nonviral sexually transmitted disease in the
world [3–5]. The control of these protozoan parasites is usually based on the improvement of
sanitary conditions to avoid infection, and the treatment of infected individuals. Several drugs,
such as metronidazole (MTZ), pentamidine, amphotericin B and derivatives, among others, are
available for the treatment of these parasitic infections. However, significant side effects have
been reported, and there is a decrease in drug susceptibility [6]. In the case of Trypanosoma,
Leishmania, and Plasmodium, an alternative approach is the interruption of disease transmission
by either preventing contacts between human beings and vectors, killing or altering the vector
life cycle. However, the effectiveness of vector control is limited by the development of insecti-
cide resistance [7–9]. Therefore, it is necessary to improve the current chemotherapy arsenal
against these protozoan parasites and their vectors. Natural treatments based on probiotics
[10, 11], propolis [12, 13], or lactoferrin [14] may represent potential therapeutic agents against
protozoan parasites. The so-called “eco-friendly control tool of mosquito vectors” based on
natural molecules derived from plants is another growing line of investigation [15–21]. The
search for new, safe, and efficient agents usually involves the identification of a biochemical
target in parasites and the development of specific inhibitors from in silico (computational),
in vitro, and in vivo experiments. Another strategy relies on the screening of known and
unknown molecules to identify active compounds. The identification of new drugs can result
from chemical modifications of existing molecules, evaluation of drugs that are currently used
to treat other diseases, screening of chemical libraries, and assessment of natural compounds
derived from plants that are commonly employed in traditional medicine [22, 23].
Plants synthesize a large number of organic compounds also called primary metabolites that
contribute to the production of carbohydrates, lipids, and proteins, among others, that are
necessary for their growth. They also generate a small amount of a variety of secondary
metabolites known as phytochemicals that are represented by alkaloids, carotenoids, flavo-
noids, saponins, hydroxycinnamic acids, and triterpenoids, among others. To date, more than
4000 of these compounds have been discovered; some of them are responsible for color and
organoleptic properties of plants, such as the red color of grapes or the characteristic smell of
lavender; others act as a natural protection system against pathogens or grazing animals [24].
Traditional medicines all around the world have identified the benefit of plants for human
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health and have taken advantage of the biological properties of phytochemicals for the empiric
treatment of common human diseases. More recently, a number of scientific experiments have
been performed to determine how a specific phytochemical can act at the molecular and
cellular levels to protect human cells against oxidative damage, to stimulate enzymes, to
interfere with the DNA replication, or to affect infection processes. These works confirmed
that natural molecules obtained from medicinal plants and their derivatives are a valuable
source of new therapeutic agents for the treatment of common human diseases and the control
of protozoan parasites and their vectors. Importantly, the key importance of natural product
research was recently highlighted by the awarding of the 2015 Nobel prize to Youyou Tu for
the discovery of the antimalarial drug artemisinin [25].
In this context, Mexico has more than 3000 species of medicinal plants that have been empir-
ically used by indigenous communities for years [26]. Some of the herbal expertise of pre-
Columbian Olmec, Toltec, Aztec, Maya, Zapotec, Mixteca and Perupecha civilizations has been
used by European doctors and scientists from the time of the conquest, which contributed to
increase the therapeutic arsenal and enrich the universal pharmacology through centuries.
Although a number of Mexican plants are currently cultivated in most countries of Europa
and other continents, there is still a large number of endemic species in Mexico that remain
uncharacterized. As part of the efforts to explore their potential, several groups of investiga-
tion have initiated chemical, toxicological, pharmacological, or clinical investigations in order
to provide rational elements for their therapeutic effects against diseases that affect the Mexican
population, mainly central nervous system disorders, diabetes, metabolic syndrome, inflam-
matory processes, and gastrointestinal disorders [27]. Notably, extensive review of ethnobo-
tanical data identified medicinal plants that are used by indigenous communities in Mexico to
treat complaints that fit with symptoms of parasitic infections. In addition to terrestrial plants,
marine algae represent a potential source of distinct secondary metabolites related to their
specific metabolism. In most cases, a general in vitro evaluation of the selected plants was
performed to confirm the traditional use. But in some cases, phytochemical studies have
allowed the isolation and identification of secondary metabolites with antiparasitic activity
(Figure 1). In this chapter, we describe the current knowledge about the effects of several
Figure 1. Strategy to search and review works about the evaluation of Mexican medicinal plants as an alternative for the
development of new compounds against protozoan parasites.
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Mexican plants against selected protozoan parasites of medical importance worldwide, includ-
ing Mexico, namely Plasmodium spp., Leishmania spp., Trypanosoma spp., G. lamblia, E histolytica,
and T. vaginalis. We also report the identification of some phytochemical compounds with
antiparasitic activity.
2. Mexican medicinal plants against Plasmodium falciparum
2.1. Plasmodium and malaria
For decades, Malaria has been considered as the most important parasitic infectious disease
worldwide, with high morbidity and mortality rates, as well as a huge socioeconomic impact
in tropical and subtropical regions. In 2015, the World Malaria Report of the World Health
Organization (WHO) estimated 214 million infected people and 438,000 deaths worldwide.
Most cases and deaths occurred in Africa (88%), followed by the South-East Asia Region.
However, for the first time, the incidence of malaria, which takes into account population
growth, has been reduced by about 37% between 2000 and 2014, and the death rate has also
been decreased by 60% worldwide. These encouraging numbers are the result of the efficient
prophylactic and therapeutic management of malaria. Notably, the case number was reduced
by 75% in several endemic countries from Asia region and South Africa and by 67.5% in Latin
America. In this region, seven countries, namely Argentina, Belize, Costa Rica, Ecuador, El
Salvador, Mexico, and Paraguay, are now in the elimination phase. In contrast, other countries
including Panama, Nicaragua, Honduras, and Guatemala still maintain a significant transmis-
sion. Despite significant advances in the control of malaria worldwide, approximately 3.2
billion people in Asia, Latin America, and to a lesser extent, Middle East, i.e., nearly half of
the world’s population, were still at risk for malaria in 2015 [9, 28–30].
Malaria is caused by protozoan parasites of the genus Plasmodium. Among the five parasites
known to infect human (P. falciparum, P. malariae, P. ovale, P. vivax, and P. knowlesi), P. falciparum
is the most virulent, causing approximately 200 million clinical cases each year, while P. vivax is
estimated to affect 13.8 million people [31]. P. falciparum is an intracellular parasite whose life
cycle requires two hosts, Anophelesmosquito (sexual stages) and human (asexual stages). More
than 70 different Anopheles species can transmit malaria, which contributes to the high spread
of the disease [32]. Infection begins with the bite of an infected female mosquito; infective
sporozoites rapidly move to the liver and proliferate (schizogony) in hepatocytes to form
30,000–40,000 merozoites that further escape into blood. In red blood cells, merozoites trans-
form into trophozoites that invade new erythrocytes; some trophozoites differentiate them-
selves into microgametocytes (male) and macrogametocytes (female) that can be ingested by
another Anopheles mosquito. These sexual parasite forms develop into a zygote, which pro-
gresses into an ookinete and an oocyst that releases sporozoites to infect a new host [33, 34].
The first symptoms of malaria also called the “primary attack” correspond to the hepatic phase
and may resemble any febrile illness. In the erythrocytic phase, fever is accompanied by
shivering, vomiting, joint pain, anemia, and retinal damage. Then, the typical symptoms of
malaria, consisting in fever with sudden coldness and sweating, occur in periodic intervals of
2–3 days known as “short-term relapses.” In some patients, “long-term relapses” of 20–60 days
Natural Remedies in the Fight Against Parasites64
may occur due to reactivation of infection in the liver (P. ovale and P. vivax) or persistent
infection in blood (P. falciparum and P. malariae) [35]. P. falciparum covers the surface of the
infected blood cells with PfEMP1 proteins (P. falciparum erythrocyte membrane protein 1) to be
sticked to blood vessels and escape destruction in the spleen. With time, this creates hemor-
rhagic events and obstruction of circulatory vessels, which leads to cerebral malaria [33].
WHO recommends artemisinin-based combination therapy (ACT) as the first-line treatment
for P. falciparum malaria in all endemic regions. ACT combines a fast acting but rapidly
cleared artemisinin derivative with a longer-lasting partner drug. The main combinations
are lumefantrine (LMF) with artemether (ATM), which constitutes the most widely used
ACT, mefloquine (MFQ) with artesunate (AS), amodiaquine (ADQ) paired with AS, and
piperaquine (PPQ) combined with dihydroartemisinin (DHA). However, the increasing
prevalence of artemisinin resistant P. falciparum across Southeast Asia and Africa threatens
to destabilize malaria control worldwide. Artemisinin resistance is caused by over 20 differ-
ent mutations in the kelch13 gene [36]. The multridug resistance 1 gene (Pfmdr1) and chloro-
quine resistance transporter gene (Pfcrt) may also confer resistance to a great number of
antimalarial drugs, including ATC [37, 38]. The recently developed vaccine, RTS,S/AS01
(RTS,S) (MosquirixTM) should help to protect young children against P. falciparum [39, 40].
However, malaria management in adult populations is still an extreme challenge and new
antimalarials with distinct mechanisms of action are needed to circumvent existing or
emerging drug resistance [41].
2.2. Relevant studies about Mexican plant with activity against Plasmodium
Plants are recognized as important sources of antimalarial compounds, such as artemisinin
obtained from Artemisia annua, quinine present in western Amazonian Cinchona spp., as well
as quassinoids and limonoids in plants of the Simaroubaceae andMeliaceae families, respectively
[42, 43]. In Mexico, about 113 species are traditionally used to treat malaria symptoms, from
which only several have been pharmacologically characterized (Table 1).
In 1990, Noster and Kraus performed the first investigations about the relevance of Mexican
medicinal plants for the development of new antimalarial compounds. These authors examined
two plants of the Rubiaceae family, Coutarea latiflora Sesse &Moc. ex. DC. (Hintonia latiflora Bullock)
and Exostema caribaeum (Jacq.) Roem. et Schult. that were collected in Puebla, Mexico. Notably,
C. latiflora also known as Copalchi is recommended to treat diabetes, stomachaches, gastric ulcers,
diarrhea, skin problems, kidney problems, fever, typhus, and malaria. E. caribaeum is used for the
treatment of gastritis, ulcers, diarrhea, stomachaches, to increase appetite and blood pressure, and
to eliminate tapeworms; bark extracts are also efficient against fever, especially fever related to
malaria. The hydrolyzed ethyl acetate extracts of the stem bark were shown to have the most
potent antimalarial activity in vitro. Notably, one phenylcoumarin derivative isolated from the
ether extract of E. caribaeum showed a moderate activity against chloroquine and pyrimethamine-
sensitive FCH-5/Tanzania strain of P. falciparum [44]. Later, fractionation of lipophilic and hydro-
philic extracts from the stem bark and branches of a related species, E. mexicanum, revealed
the presence of two new 4-phenylcoumarins: 4',8-dihydroxy-5,7-dimethoxy-4-phenylcoumarin
(exomexin A) and 3',4'-dihydroxy-5,7,8-trimethoxy-4-phenylcoumarin (exomexin B). Exomexin
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Scientific names Common names in
Mexico
Portions Extracts Properties Metabolites References
Mexican medicinal plants against Plasmodium
Exostema caribaeum Quina, melena de león Stem bark Ethyl acetate IC50 = 3.2 µg/ml Phenylcoumarin derivative [32]
Hintonia latiflora (=
Cuntarea latiflora)
Copalchi, palo amargo Stem bark Ethyl acetate IC50 = 7.3 µg/ml
In vivo activity against schizonts
at 40 mg/kg.
IC50 = 24.7 and 25.9 µM
IC50 = 25.9 µM
Phenylcoumarin derivative
5-O-β-D-glucopyranosyl-7,4´-
dimethoxy-3´-hydroxy-4-
phenylcoumarin
5-O-β-D-glucopyranosyl-7-methoxy-
3´,4´-dihydroxy-4-phenylcoumarin
[32]
[34]
Mexican medicinal plants against T. cruzi
Aristolochia taliscana Guaco Roots Methanol In vitro activity on epimastigotes
at 0.5 mg/ml
Neolignans (aupomatenoid-7 licarin
A, aupomatenoid-1 and licarin B)
and lignans (austrobailignan-7, and
fragransin E1).
[42]
Persea americana Aguacate Seeds Methanol IC50 (epimastigotes) = 82 µM
IC50 (trypomatigotes) = 49 µM
1,2,4-Tri-hydroxyheptadec-16-ene,
1,2,4-tri-hydroxyheptadec-16-yne
and 1,2,4-trihydroxinonadecane
derivatives
[43]
Senna villosa Booxsaal che, saal che,
black bean
Leaves Chloroform In vitro activity on epimastigotes
at 1.6 mg/ml
8-Hydroxymethylen)-triecosanyl [44]
Haematoxylum
brasiletto
Palo de brasil Leaves and
aerial parts
Methanol In vitro activity on epimastigotes
at 7.92 mg/ml
Hematoxylin, Brazilin, Caffeic acid,
Gallic acid, Methyl gallate,
phloroglucinol, 4-hydroxycinnamic
acid and 5-methoxypsoralen
[46]
Mexican medicinal plants against Leishmania
Pentalinon andrieuxii Bejuco guaco,
cantibtec, contrayerba
Leaves and
roots
Water In vitro activity on
promastigotes at 10 μg/ml
6,7-Dihydroneridienone, Cholest-4-
en-3-one
[53]
Laennecia confusa ND Aerial parts Water
Chloroform
IC50 ~20 µg/ml Flavonoids, Cyanogenic Glycosides
and Cardiotonic
Saponins, Sesquiterpene Lactones
and Triterpenes
[55]
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Scientific names Common names in
Mexico
Portions Extracts Properties Metabolites References
Mexican medicinal plants against G. lamblia and E. histolytica
Zanthoxylum
liebmannianum
Colopahtle Leaves Ethanol IC50 (Eh) = 503.48 µg/ml
IC50 (Gl) = 58 µg/ml
Asarinin [64]
Teloxys graveolens Epazote de zorrillo Aerial parts Methanol IC50 (Eh) = 12.5 µg/ml
IC50 (Gl) = 16.8 µg/ml
IC50 (Eh) = 17.2 µg/ml
Melilotoside
Narcissin
[65]
Rubus coriifolius Zarzamora Aerial parts Methanol:dichloro
methane
IC50 (Eh) = 11.6 µg/ml
IC50 (Gl) = 55.6 µg/ml
(-)-Epicatechin [66]
Geranium mexicanum Pata de León Roots Dichloromethane–
MeOH
IC50 (Eh) = 1.9 µg/ml
IC50 (Gl) = 1.6 µg/ml
(-)-Epicatechin [68]
Decachaeta incompta ND Leaves Dichloromethane IC50 (Eh) = 2.6 μg/ml
IC50 (Gl) = 18.1 μg/ml
Incomptine A [71]
Salvia polystachya Chia Aerial parts Acetone IC50 (Eh) = 22.9 µM
IC50 (Gl) = 28.2 µM
IC50(Eh) from 117.0 to 160.6 µM
IC50 (Gl) from 107.5 to 134.7 µM
Linearolactone
Polystachynes A, B and D
[73]
Lepidium virginicum pich’ tuluk’ Roots Methanol IC50 (Eh) = 100.1 µg/ml Benzyl glucosinolate [76]
Lippia graveolens
Ruta chalepensis
Aerial parts Methanol IC50 (Eh) = 44.3 μg/ml
IC50 (Eh) = 45.95 μg/ml
Carvacrol
Chalepensin
[77]
Adenophyllum
aurantium
Arnica silvestre Roots Ethyl acetate IC50 (Eh) = 230 µg/ml Thiophenes [78]
Hippocratea excelsa Cancerina Roots Hexane/ethanol IC50 (Gl) = 0.11 µM
IC50 (Gl) = 0.74 µM
Pristimerine tingenone [83]
Geranium mexicanum
Rubus coriifolius
Cuphea pinetorum
Helianthemum
glomeratum
Pata de léon
Zarzamora
Cenicilla o hierba de la
gallina
Roots
Aerial parts
Aerial parts
Leaves
Dichloromethane/
methanol
ED50 (Gl) = 0.072 µmol/kg
ED50 (Gl) = 2.057 µmol/kg
ED50 (Gl) = 1.429 µmol/kg
()-Epicatechin
Kaempferol
Tiliroside
[84]
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Scientific names Common names in
Mexico
Portions Extracts Properties Metabolites References
Mexican medicinal plants against T. vaginalis
Carica papaya
Cocos nucifera
Bocconia frutescens
Geranium mexicanum
Lygodium venustum
Papaya
Cocotero, coyolli
ts’ixte’
Geranio de olor, Pata de
león
Bejuco chino, crispillo
Seeds
husk fiber
Aerial parts
Roots
Aerial parts
Methanol IC50 = 5.6 µg/ml
IC50 = 5.8 µg/ml
IC50 from 30.9 to 60.9 µg/ml
Sanguinarine alkaloid [99]
Lobophora variegata
Udotea conglutinata
ND
ND
Whole Dichloromethane/
methanol
IC50 = 1.3  0.7 µg/ml
IC50 = 1.6  0.1 µg/ml
Sulfoquinovosyl-diacylglycerols 1-3 [100, 101, 103]
ND = not determined.
ED50, effective dose 50; IC50, half-maximal inhibitory concentration; MC100, concentration inducing 100% of the maximum response.
Gl, G. lamblia; Eh, E. histolytica.
Table 1. Names and metabolites of the most relevant Mexican medicinal plants with activity against selected protozoan parasites.
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A, the most lipophilic molecule, had the strongest in vitro activity against the chloroquine-sensi-
tive strain (poW) and the chloroquine-resistant strain (Dd2) of P. falciparum, with half-maximal
inhibitory concentration (IC50) values of 3.6 and 1.6 µg/ml, respectively [45]. In another study,
Argotte-Ramos et al. [46] confirmed that ethyl acetate extract of the stem bark of H. latiflora was
also able to suppress parasitemia in mice infected with P. berghei. Bioassay-directed fractionation of
the extract showed that this activity was due to two 4-phenylcoumarins, the new 5-O-β-D-
glucopyranosyl-7,40-dimethoxy-30-hydroxy-4-phenylcoumarin and the previously reported 5-O-β-
D-glucopyranosyl-7-methoxy-30,40-dihydroxy-4-phenylcoumarin.This latter molecule suppressed
the development of schizonts by 70.8% at the dose of 40 mg/kg in the in vivo model. Both
compounds were also effective against P. berghei schizonts in in vitro experiments with IC50 values
of 24.7 and 25.9 µM, respectively. More recently, Rivera et al. [47] reported that methanolic extract
of H. latiflora stem bark (HlMeOHe) also has an antimalarial efficacy. Toxicity assays showed that
median lethal dose (LD50) was 2783.71 mg/kg. P. yoelii yoelii-infected mice treated with 600 and
300 mg/kg died after 6 and 7 days, respectively, with parasitemia around 45% versus 70% in
untreated mice. Interestingly, treatment with 1200 mg/kg led to a 23 days survival time with a
residual parasitemia of 23.6%. However, HlMeOHe seemed to be mutagenic since the average
number of micronuclei significantly increased from 0.9 in untreated to 4.8 in treated mice. The
authors concluded that the identification of the chemical composition of HlMeOHe should help to
reduce its genotoxic potential.
Artemisia ludoviciana ssp. mexicana of the Compositae family has been empirically used for the
treatment of intermittent fever and other symptoms. Malagon et al. [48] prepared ethanolic
extracts from steams, leafs, and flowers to evaluate their activity in mice infected with P. yoelii
yoelii. Results showed that parasite reproduction was inhibited up to 98.6% at the 5th day; the
effective dose 50 (ED50) was of 29.2 mg/kg with a security margin 50 (SM50) of 28.7. Surpris-
ingly, this extract did not seem to contain the artemisinin molecule discovered in the leaves of
A. annua and that is the basis of ACT, which suggests the anti-Plasmodium effect may be due to
another active molecule.
As part of an ethnobotanical study in Yucatan, Mexico (February 1994–June 1995; September
1996–October 1996), medicinal plants used by Mayan communities were collected from
Chikindzonot, Ekpedz, and Xcocmil villages and surroundings to confirm their pharmacolog-
ical relevance [49]. Notably, several species that are commonly recommended against fever or
pain were screened in vitro for antimalarial activity, such as Cestrum nocturnum, also known as
night-blooming jasmine, an evergreen woody shrub of the Solanaceae family, Casearia
corymbosa, a 15-m high tree belonging to the Salicaceae family, and Caesalpinia gaumeri, a tree
with deeply fluted and perforated trunk that belongs to the Fabaceae family. They also evalu-
ated Ehretia tinifolia, a 25-m tree of the Boraginaceae family, whose pinguicas are traditionally
used for nervous disorders and kidney problems, while the bark is used for wound healing, as
well as Manilkara zapota, commonly known as the sapodilla, a long-lived, evergreen tree native
from southern Mexico, Central America, and the Caribbean, which has curative properties
against dysentery and diarrhea, fever, diuretics, high blood pressure, and pain caused by picket
scorpion. Interestingly, nonpolar extracts of leaves from C. nocturnum, C. corymbosa, C. gaumeri
and E. tinifolia showed different levels of antimalarial activity against both chloroquine-
sensitive HB3 and chloroquine-resistant K1 strains of P. falciparum, with IC50 ranging from
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172.49 to >500 µg/ml. In the case of M. zapota, nonpolar extract of stem bark was the most
effective with an IC50 value higher that 500 µg/ml.
3. Mexican medicinal plants against Trypanosoma cruzi
3.1. Trypanosoma cruzi and American trypanosomiasis
T. cruzi is the causative agent of American trypanosomiasis or Chagas disease, which is the
third cause of death in Latin America after malaria and schistosomiasis. Between 16 and 18
million people are affected by this disease that kills annually about 50 thousand people;
importantly, 100 million people (25% of the population of Latin America) are at risk of
contracting this infection [50].
T. cruzi is mainly transmitted bya triatomine bug (Triatoma infestans). In the vector, trypomastigote
goes into the epimastigote stage that reproduces through binary fission in midgut to form
metacyclic trypomastigotes. This infectious stage enters the human host through the bite wound
or by crossingmucousmembranes, and transforms into amastigotes in infected cells. Intracellular
amastigotes can evolve into trypomastigotes that burst out of the cell and enter the blood stream
to be transmitted to another triatomine bug. Nonvector transmission has also been described,
mainly through oral infection, blood transfusions, congenital transmission, organ transplantation,
and laboratory accidents [51].
Chagas disease has an acute and a chronic phase. The acute phase lasts for the first few weeks
or months of infection; it can be asymptomatic or include fever, fatigue, and local swelling
(called chagoma). In the chronic phase, patients usually have cardiac abnormalities, as well as
digestive, neurological, or mixed alterations; recently, it has been shown that they also have
behavioral changes, such as psychomotor alterations, attention and memory deficits, as well as
depression [52]. Chemotherapy involves the use of two drugs: nifurtimox and benznidazole.
However, both agents have variable efficacy in the acute phase and are ineffective in the
chronic stage; moreover, they produce severe adverse effects [53].
3.2. Relevant studies about Mexican plant with activity against Trypanosoma cruzi
Because of the epidemiologic relevance of Chagas disease in Mexico, the traditional medicine
has identified several Mexican plants that can help to control this infection (Table 1). Based on
this knowledge, Abe et al. [54] performed a screening of crude methanolic extracts of several
medicinal plants (20 families and 37 species) against epimastigotes of T. cruzi. Results showed
that 18 extracts had a trypanocidal effect at a concentration of 2 mg/ml, and 13 extracts showed
a trypanocidal activity at 1 mg/ml. The methanolic extract of root from Aristolochia taliscana, a
medicinal species known as guaco that is used to treat bites of snakes, cough, diarrhea, and
dermatological conditions, had the highest biological activity immobilizing all epimastigotes
at a concentration of 0.5 mg/ml. Phytochemical study allowed the identification of six second-
ary metabolites: four neolignans (aupomatenoid-7 licarin A, aupomatenoid-1, and licarin B)
and two lignans (austrobailignan-7 and fragransin E1). The best trypanocidal activity was
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found for aupomatenoid-7 and fragrasin E1, with a minimum concentration (MC100) value of
25 and 50 µg/ml, respectively. The structure-activity relationship (SAR) analysis determined
that loss of the hydroxyl group reduces the trypanocidal activity. In addition, the authors
suggested that steric effects might be affecting the biological behavior.
Following with the search of new options for the treatment of Chagas disease, Abe et al. [55]
studied another set of Mexican medicinal plants belonging to 41 families and 65 species. Only
one extract had a strong trypanocidal activity against epimastigotes of T. cruzi, while 10 extracts
presented a weak activity. However, 39 extracts showed a good activity against trypomastigotes
since concentrations inducing 100% of the maximum response (MC100) were between 125 and
500 µg/ml. The methanolic extract of seed from Persea americana (Lauracea family), a tree native
from Central Mexico that produces avocado, showed the best activity on epimastigotes. The
phytochemical analysis of the extract identified three 1,2,4-tri-hydroxyheptadec-16-ene deriva-
tives, three 1,2,4-tri-hydroxyheptadec-16-yne derivatives, and two 1,2,4-trihydroxinonadecane
derivatives. The most active compound was a 1,2,4-tri-hydroxyheptadec-16-ene (IC50 = 82 and
49 µM against epimastigotes and trypomatigotes, respectively). The SAR analysis determined
that the transformation of the group 16-ene terminal by a group 16-yne reduces the activity.
Senna villosa is a leguminous plant of southeastern Mexico, with antifungal and antimicrobial
activities, usually used to treat stomach disorders (laxative), dysmenorrhea, or fungal infection.
Phytochemicals analysis has identified alkaloids, sterols, flavonoids, and anthraquinones as
secondary metabolites. Particularly, Jimenez-Coello et al. [56] showed that crude chloroformic
extracts had trypanocidal activity in vitro against epimastigotes of T. cruzi at a concentration of
1.6 mg/ml. The main metabolite responsible for the activity in in vitro experiments and in vivo
models (33.6 mg/g) was (8-hydroxymethylen)-trieicosanyl acetate. Therefore, the same group
of investigations tested chloroformic extracts of S. villosa leaves against amastigotes of T. cruzi
during the acute phase of infection. Results showed a reduction in the number of amastigotes
in cardiac tissue at a dose of 3.3 mg/g compared with untreated mice [57].
Molina-Garza et al. [58] evaluated the trypanocidal activity of 10 plants used in traditional
Mexican medicine for the treatment of parasitic infections: Artemisia Mexicana, Castela texana,
Cymbopogon citratus, Eryngium heterophyllum, Haematoxylum brasiletto, Lippia graveolens,
Marrubium vulgare, Persea americana, Ruta chalepensis, and Schinus molle. Methanolic extracts
(150 mg/ml) of E. heterophyllum, H. brasiletto, M. vulgare, and S. molle produced growth inhibi-
tion (88–100%) of T. cruzi epimastigotes. C. citratus and A. mexicana led to 83% inhibition,
P. americana and R. chalepensis to 70%, and C. texana and L. graveolens to 33% inhibition. The
highest values of trypanocidal activity (7.92 and 11.24 mg/ml) were for H. brasiletto and
E. heterophyllum, respectively. The phytochemical characterization of H. brasiletto indicated the
presence of hematoxylin, brazilin, caffeic acid, gallic acid, methyl gallate, phloroglucinol,
4-hydroxycinnamic acid, and 5-methoxypsoralen. Constituents of E. heterophyllum extracts
have not been described yet, although the presence of (E)-2-dodecanal, a metabolite with
trypanocidal activity, has been found in the related specie E. foetidum. H. brasiletto extracts also
have unsaturated compounds, including carbonyl groups, carboxyl groups, triterpenes, ses-
quiterpene lactone, quinones, flavonoids, and tannins [59].
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Carica papaya, a giant herbaceous plant in the Caricaceae family, is originated in Central Amer-
ica and widely distributed in southern Mexico. It is traditionally used for diabetes treatment
and birth control, as antiseptic, antimicrobial, or diuretic, to control parasites, lower blood
pressure and cholesterol, and reduce inflammation, among others. Some data also indicated
that it has antiprotozoal activity. Therefore, Jimenez-Coello et al. [60] evaluated the effects of
extracts and a mixture of the main components of C. papaya against T. cruzi amastigotes during
subacute phase and chronic disease. Results showed that chloroformic extract was able to
reduce the number of amastigotes (55.5 and 69.7%) in cardiac tissue of infected mice during
the subacute phase at a concentration of 50 and 75 mg/kg, respectively. The fatty acids mixture
also exhibited a similar trypanocidal activity (56.45%); however, the total elimination of the
parasite was not achieved. In the chronic phase of infection, the number of amastigotes was
only reduced to 46.8 and 5.13% using the same concentrations. Therefore, the authors
suggested the use of this extract in combination with other reference drug for a more efficient
pharmacological treatment of Chagas disease.
T. brucei is the other pathogen genus that is responsible for the African trypanosomiasis also
known as sleeping sickness. Due the medical relevance of this parasitic infection and problems
with conventional treatments, medicinal plants have been investigated to develop alternative
drugs. Unfortunately, the potential of Mexican medicinal plants against this parasite does not
seem to have been investigated yet; therefore, we did not include this topic in the present
review.
4. Mexican medicinal plants against Leishmania
4.1. Leishmania and leishmaniasis
Cutaneous, mucocutaneous, and visceral (kala-azar) leishmaniasis are caused by more than 20
species of Leishmania, mainly L. donovani, L. infantum, or L. chagasi, in the case of visceral
disease, while cutaneous forms can be due to more than 15 different species. All species are
morphologically identical, but specific biochemical and molecular characteristics allow their
identification through isoenzyme analysis, molecular methods, or monoclonal antibodies. This
set of parasitic infections affects 88 countries worldwide, 67 in the old world, and 21 in
America. The large majority (90%) of visceral leishmaniasis cases is reported in only five
countries: Bangladesh, India, Nepal, Sudan, and Brazil, while cutaneous leishmaniasis mainly
affects seven countries: Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia, and Syria. The
annual incidence is estimated at 1.5 million cases of cutaneous, mucocutaneous, and diffuse
cutaneous leishmaniasis and, 500,000 cases of visceral leishmaniasis. There are 350 million
people at risk of contracting the disease, which is associated with about 2.4 million people
with disabilities and about 70,000 deaths per year [61, 62].
Leishmania infection begins with the inoculation of promastigotes by a sand fly from
Phlebotomus or Lutzomyia genus during blood meals. After being phagocytized by macro-
phages or other mononuclear phagocytic cells, parasite evolves to amastigotes that multiply
and infect other mononuclear cells. The life cycle is continued when a sand fly feeds on an
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infected person and ingests amastigotes within macrophages. In the insect gut, amastigotes
transform into promastigotes that migrate to the proboscis to be transmitted to another human
host [63].
Cutaneous leishmaniasis is characterized by skin ulcers that are be cured by themselves, while
mucocutaneous leishmaniasis is associated with progressive infection with invasion and destruc-
tion of the nasopharyngeal mucosa. Symptoms of visceral leishmaniasis mainly include fever,
weight loss, enlargement of spleen and liver, as well as low blood counts. Treatment depends on
the Leishmania species, the clinical signs, the geographic region, and the immunologic status of
the patient. Visceral leishmaniasis is usually treated with liposomal amphotericin B, and recently
by miltefosine (Miltex), although the pentavalent antimony (SbV) and paromomycin (Humatin)
are also used in developing countries. The same treatments can also be used for severe cases of
cutaneous or mucocutaneous disease. Most of these drugs cause serious problems, including
renal insufficiency. In addition, their high cost makes treatment unaffordable for most infected
people. Therefore, a large number of patients discontinue the treatment, which promotes the
emergence of resistant strains [64].
4.2. Relevant studies about Mexican plant with activity against Leishmania
Besides the relevance of Leishmaniasis in Mexico, the study of Mexican plants as an option for
the treatment of this infectious disease has been limited (Table 1). Pentalinon andrieuxii, a
flowering plant in the Apocynaceae family, is a native plant of the state of Yucatan, Mexico that
has been commonly used for the treatment of cutaneous leishmaniasis in southeastern Mexico.
Lezama-Davila et al. [65] reported that aqueous and organic extracts of P. andrieuxii root (10
μg/ml) have activity on promastigotes of L. mexicana in vitro. The extracts of leaves and roots
contain various secondary metabolites, mainly cardenolides, flavonoids, pregnane sterols,
trinorsesquiterpenoids, and triterpenoids. Phytochemical analyses of root hexane extract
revealed 16 sterol derivatives, three coumarins, and one triterpenoid. The evaluation of their
effect on promastigotes and amastigotes of L. mexicana showed that five sterols have a greater
inhibitory effect than the reference drug, pentostam, after 48 h exposure on promastigotes;
notably, 6,7-dihydroneridienone was the most active metabolite with an IC50 value of 9.2 µM.
These compounds were as effective as pentostam against amastigotes, with IC50 values from
1.4 to 3.5 µM versus 2.7 µM, respectively. Cholest-4-en-3-one was the most active metabolite
with an IC50 value of 0.03 µM against the amastigote form. The SAR analysis showed the
importance of fragment 4-ene-3-oxo in the steroidal system for the leishmanicidal effect, while
the 3-ol-5-ene system reduced the antiparasitic activity. Variations in chain size on D ring of
five members also influenced the activity. Interestingly, none of these compounds showed
cytotoxic effects (IC50 >100 µg/ml) on noninfected bone marrow-derived macrophages from
C57BL16 mouse. Authors suggested that these compounds may act as antagonists of endoge-
nous sterols, interfering or inhibiting sterol biosynthesis, causing alterations in membrane of
L. mexicana, and leading to morphological abnormalities and destruction of amastigotes [66].
Infusion of Laennecia confusa (Asteraceae family), native of the states of Chihuahua and Chiapas,
Mexico, is used as sedative and treatment for alcohol addiction. The genus Laennecia contains
several secondary metabolites, such as terpenoids, terpenes, saponoides, flavonoids, sterols,
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lactones, and tannins, among others. When Martínez-Ruiz et al. [67] evaluated the trypanocidal
potential of L. confusa, they confirmed the presence of flavonoids, cyanogenic glycosides and
cardiotonic, saponins, sesquiterpene lactones, and triterpenes, in 71 fractions obtained from aque-
ous, hexanic, methanolic, and chloroformic extracts. Aqueous and chloroformic extracts caused a
significant growth reduction of L. donovani with IC50 values around 20 µg/ml; interestingly, the
IC50 value decreased to 200 µg/ml for a specific fraction of the chloroformic extract. Unfortu-
nately, all compounds exhibited toxicity on macrophages.
Lopezia racemosa (also known as L. mexicana, L. hirsute Jacq.), widely distributed in Mexico, is
traditionally used for skin infections, stomach cancer, and urinary retention, among others. It
has been reported that plants of the Onagraceae family contain tannins, flavonoids, and sterols
as metabolic constituents; however, L. racemosa has not been submitted to phytochemical
studies yet. Cruz-Paredes et al. [68] evaluated the effect of hexane, chloroform, and methanol
extracts (HE, CE, and ME) of L. racemosa and their fractions on L. donovani promastigotes.
Interestingly, HE 11-14b and ME 28-36 fractions and CE produced a high reduction (88%) in
parasites number when compared with untreated controls. However, most extracts and frac-
tions had a toxic effect on human-derived macrophages (THP-1); only fraction 28–36 ME
showed no significant cytotoxicity (below 25%) (IC50 = 770 µg/ml). The authors hypothesized
that the high amount of polyphenols (tannins and flavonoids) present in this plant may be
responsible for the biological activity.
5. Mexican medicinal plants against gastrointestinal protozoan parasites
5.1. Entamoeba histolytica and Giardia lamblia
Gastrointestinal diseases occur worldwide and are associated with poor sanitary conditions,
overcrowding, poor water quality control, and low socioeconomic level. Different microorgan-
isms can produce these symptoms; two of them are the protozoan parasites E. histolytica and
G. lamblia (or G. intestinalis or G. duodenalis). E. histolytica is responsible for human amoebiasis.
Trophozoites live and proliferate in the intestinal tract by eating bacteria and cellular debris. In
some cases, parasites cross the epithelial wall to reach the bloodstream and spread throughout
the body to invade other organs, mainly liver, as well as lungs, brain, or spleen. Trophozoites
can also form cysts that are eliminated with feces. Most infected patients are asymptomatic;
others present a wide range of symptoms including diarrhea, stomachache, and hemorrhagic
colitis. The extraintestinal localization of trophozoites can produce fatal abscesses. Amoebiasis
remains a major health problem, affecting more than 10% of the world’s population, mainly in
developing countries. Globally, it accounts for 50 million clinical cases and is responsible for
approximately 110,000 deaths annually, which makes it the second-leading cause of death
from a protozoan parasite after malaria [69–71]. Giardiasis, also called Beaver fever, is the
other common intestinal infection associated with diarrhea, producing over 250 million symp-
tomatic human infections per year worldwide, with a high prevalence in children in develop-
ing countries. The flagellated protozoan G. lamblia is the causal agent of giardiasis.
Colonization of the small intestine produces acute or chronic diarrhea, mal absorption, excess
gas, stomach or abdominal cramps, nausea, and failure to thrive. Giardia infection also alters
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child linear growth and psychomotor development, due to iron-deficiency anemia, micronu-
trient deficiencies and growth retardation associated with diarrhea and malabsorption syn-
drome [72]. Both E. histolytica and G. lamblia are transmitted by the fecal-oral route, through
ingestion of food and water that have been contaminated by feces of an infected host.
Metronidazole and other 5-nitroimidazoles are the drugs of choice against E. histolytica and
G. lamblia; however, there are some reports about their mutagenicity in bacteria and their
carcinogenic effects in rodents. Additionally, metronidazole provokes several side effects,
including headache, dry mouth, metallic taste, glossitis, and urticaria [73–75].
5.2. Relevant studies about Mexican plants with activity against Entamoeba histolytica and
Giardia lamblia
Mexican native communities use a large number of plants to treat intestinal ailments. However,
only few species have been scientifically evaluated to confirm their potential such as anti-Giardia
or anti-Entamoeba treatments (Table 1). Zanthoxylum liebmannianum, commonly known as
Colopahtle, is recommended for the treatment of stomachaches, amoebiasis, intestinal parasites,
and as a local anesthetic agent. The crude ethanol extract from leaves of Z. liebmannianum
exhibited an inhibitory effect on the proliferation of E. histolytica and G. lamblia trophozoites with
IC50 values of 3.48 and 58.00 µg/ml, respectively. Asarinin, hyperin, β-sitosterol, and β-sitosterol
glucoside were isolated from this extract. Among them, asarinin was the most active compound
with IC50 values of 19.86 µg/ml for E. histolytica and 35.45 µg/ml forG. lamblia [76].
In 2003, Calzada et al. [77] reported the isolation and antiprotozoal activity of one coumaric
acid derivative, named melilotoside, and the flavonoids pinocembrine, pinostrobin, chrysin,
narcissin, and rutin from Teloxys graveolens, a medicinal plant traditionally used to control
some gastrointestinal diseases. Melilotoside exhibited the most potent activity toward
E. histolytica and G. lamblia with IC50 values of 12.5 and 16.8 µg/ml, respectively. Interestingly,
narcissin showed selectivity against E. histolytica (IC50 = 17.2 µg/ml).
The same year, Alanís et al. [78] isolated (-)-epicatechin, (+)-catechin, hyperin, nigaichigoside
F1, B-sitosterol 3-O-β-D-glucopyranoside, gallic acid, and ellagic acid from Rubus coriifolius, a
medicinal plant used by the Maya communities in southern Mexico to treat bloody diarrhea.
These compounds had activity against E. histolytica and G. lamblia trophozoites, being (-)-
epicatechin the most potent molecule with the IC50 values of 1.9 and 1.6 µg/ml, respectively.
(-)-Epicatechin is also obtained from Geranium mexicanum, with the vernacular name pata de
leon, an endemic Mexican species used as purgative, and as a remedy against tonsillitis, cough,
whooping cough, urticaria, dysentery, and diarrhea. This flavonoid was active against
E. histolytica and G. lamblia with IC50 values ranging from 1.9 to 79.2 µg/ml for E. histolytica
and from 1.6 to 100.4 µg/ml for G. lamblia. In addition, G. mexicanum contains (+)-catechin,
tyramine, and β-sitosterol 3-O-β-D-glucopyranoside, but they only had a moderate activity
against these protozoan parasites [79].
In northeast Mexico, indigenous populations use infusion of leaves from Artemisia ludoviciana
as an antidiarrheal treatment. Aqueous, methanolic, acetonic, and hexanic leaf extracts from
plants collected in Monterrey City, Mexico, were found to be active in vitro against both
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E. histolytica and G. lamblia trophozoites. Particularly, the acetonic (IC50 = 117.2 µg/ml) and
hexanic (122.7 µg/ml) extracts showed an interesting activity against E. histolytica, while the
hexanic extract had the highest effect upon G. lamblia (IC50 = 137.4 µg/ml) [80]. A. ludoviciana
was also studied by Ramos-Guerra et al. [81], together with M. vulgare, Mentha spicata, and
Chenopodium ambrosioides that are also popularly used against intestinal disorders. Surpris-
ingly, A. ludoviciana was inactive against both protozoan species (IC50 >100 µg/mL) in this
work. Acetonic and methanolic extracts from M. vulgare were very active against G. lamblia
with an IC50 = 7 and 12 µg/ml, respectively, and slightly to moderately toxic to E. histolytica
(IC50 = 90 and 34 µg/ml, respectively). Hexanic, acetonic, and methanolic extracts from
M. spicata were also very potent against G. lamblia (IC50 = 17, 13, and 8 µg/ml, respectively)
while only the acetonic extract was slightly active against E. histolytica (IC50 = 98 µg/ml). Hexanic
and acetic C. ambrosioides extracts were moderately active against amoeba (IC50 = 57 and 58 µg/
ml). The highest activity against both protozoan species was obtained with organic extract from
M. vulgare andM. spicata, which require further studies to identify the active compounds.
Decachaeta incompta is a Mesoamerican flowering plant that has been traditionally used in
Oaxaca, as well as in Chiapas, Colima, Guerrero, Michoacán, Mexico State, Jalisco, and Puebla,
Mexico. Its antiprotozoal properties have been confirmed since the dichloromethane extract of
leaves was effective against E. histolytica and G. lamblia trophozoites (IC50 values of 132.5 and
141.4 µg/ml, respectively). Bioassay-guided fractionation of crude extract resulted in the isola-
tion of four sesquiterpene lactones named incomptines. Incomptine A, a sesquiterpene lactone
of the heliangolide type, appeared to be the most potent antiamoebic and antigiardial com-
pound with IC50 values of 2.6 µg/ml for E. histolytica and 18.1 µg/ml for G. lamblia. Its potency
against E. histolytica was close to that of emetine (IC50 1.05 µg/ml) [82]. Recently, we used a
proteomic approach based on two-dimensional gel electrophoresis and electrospray ionization
tandem mass spectrometry (ESI-MS/MS) analysis to get insights into the molecular mecha-
nisms involved in the antiamoebic activity of incomptine A. Our results evidenced the differ-
ential expression of 21 E. histolytica proteins in response to incomptine A treatment. Notably,
three glycolytic enzymes, namely enolase, pyruvate:ferredoxin oxidoreductase and fructose-
1,6-biphosphate aldolase, were downregulated. In addition, we observed an increased number
of glycogen granules through ultrastructural analysis of trophozoites by electronic microscopy.
Based on these data, we proposed that incomptine A could affect E. histolytica growth through
alteration of energy metabolism [83].
Salvia polystachya Ort. (Lamiaceae), popularly known as chia is used in Mexican traditional
medicine as a purgative, antigastralgic, antipyretic, and to treat dysentery. In 2010,
Calzada et al. [84] evaluated the possible antiprotozoal in vitro activity of the crude extract
and four neo-clerodane diterpenoids from S. polystachya. They found that linearolactone was
the most potent antiamoebic and antigiardial compound with IC50 values of 22.9 and 28.2 µM,
respectively. Polystachynes A, B, and D showed moderate antiprotozoal activity with IC50
values ranging from 117.0 to 160.6 µM for E. histolytica and from 107.5 to 134.7 µM for
G. lamblia.
Since amoebiasis and giardiasis share intestinal symptoms, several groups of investigation
used a screening approach to simultaneously evaluate the antiamoebic and antigiardial effects
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of a large number of Mexican medicinal plants that are recommended for gastrointestinal
diseases. In 2006, Calzada et al. [85] studied 26 plants and found that methanolic extract
obtained from Chiranthodendron pentadactylon, Annona cherimola, and Punica granatum was the
most effective on E. histolytica with IC50 < 30 µg/ml. Interestingly, C. pentadactylon had an IC50
value of 2.5 µg/ml, which is close to the IC50 value of emetine, but far less than metronidazole
used as control drugs. On the other hand, extracts of Dorstenia contrajerva, Senna villosa, and
R. chalepensiswere the most active toward G. lambliawith IC50 < 38 µg/ml. Recently, Camacho-
Corona et al. [86] showed that the dichloromethane/methanol extract of Larrea tridentata, also
known as gobernadora (governess) and hediondilla (little smelly one) in Mexico, exhibits a
moderate inhibitory activity against E. histolytica (IC50 = 100 µg/ml). The extract of Hyptis
albida was the most active against G. lamblia with an IC50 value of 16.11 µg/ml. Extracts of
Crataegus mexicana, Ocimun basilicum, and L. tridentata exhibited a moderate activity against
G. lamblia with IC50 values of 153 and 116 µg/ml, respectively.
5.3. Relevant studies about Mexican plant with activity against Entamoeba histolytica
Although amoebiasis and giardiasis share several symptoms, the protozoan parasites that
are responsible for these infectious diseases are quite different. Therefore, several investiga-
tors focused their research on Entamoeba or Giardia to confirm the ethnobotanical properties
of Mexican medicinal plants used to treat intestinal diseases and identify the phytochemicals
that are responsible for their activity against these endemic pathogens (Table 1). Thus,
Calzada et al. [87] reported scientific findings that support the ethnomedical use of roots of
Lepidium virginicum, a herb of the highlands of Chiapas, Mexico, which is recommended for
the treatment of diarrhea and dysentery. The crude extract of L. virginicum roots exhibited
in vitro activity against E. histolytica trophozoites (IC50 = 100.1 µg/ml). Extract fractionation
revealed that benzyl glucosinolate is responsible for this activity with an IC50 of 20.4 µg/ml.
Later, Quintanilla-Licea et al. [88] performed an antiamoebic screening among methanolic
extracts of 32 plants used in northeast Mexican traditional medicine. Six extracts induced
more than 80% growth inhibition at a concentration of 150 µg/ml. L. graveolens Kunth and
R. chalepensis Pers. showed the most significant antiprotozoal activity (91.54 and 90.50%
growth inhibition at a concentration of 150 µg/ml with IC50 values of 59.14 and 60.07 µg/ml,
respectively). Bioassay-guided fractionation of the methanolic extracts afforded carvacrol (IC50
= 44.3 µg/ml) and chalepensin (IC50 = 45.95 µg/ml), respectively, as bioactive compounds.
Recently, Herrera-Martínez et al. [89] reported that ethyl acetate extract of Adenophyllum
aurantium root exhibits antiamoebic activity in vitro with an IC50 of 230 µg/ml. This extract
was also able to inhibit the encystation process of E. invadens, the protozoan parasite of reptiles.
Interestingly, this extract affected virulence properties of amoeba, since the intraperitoneal
administration (2.5 or 5 mg) to E. histolytica-infected hamsters prevented the development of
amoebic liver abscesses in 48.5 or 89.0% of the animals, respectively. Moreover, adhesion and
erythrophagocytosis were 28.7 and 37.5% inhibited, respectively. These effects were associated
with alterations in trophozoite organization, namely a reduced number of vacuoles and alter-
ations in the actin cytoskeleton. Thiophenes were identified as the major components by carbon-
13 nuclear magnetic resonance (13C-NMR) analysis; however, their relevance for antiamoebic
activity remains to be confirmed.
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5.4. Relevant studies about Mexican plant with activity against Giardia lamblia
In an attempt to characterize the in vitro activity against Giardia, Ponce-Macotela et al. [90]
evaluated 14 medicinal plants commonly used as antidiarrheic and antiparasitic treatment in
Mexico. Nine species presented a clear antigiardial effect when they were used at the concen-
trations traditionally recommended. Notably, Justicia spicigera, Lipia beriandieri, and Psidium
guajava produced a higher mortality (91  0.5%, 90  0.6%, and 87  1.0%, respectively) than
tinidazole used as reference drug (79  1.9%). Later, the same group of investigation reported
that trophozoites exposed to J. spicigera extract have significant changes in ultrastructure,
mainly modification in size and shape, as well as damage in nucleus structure, which may be
due to alterations in the pattern of nucleoskeleton proteins as a result of the effects of plant
phytochemicals [91, 92].
The state of Yucatan, Mexico, is a rich source of Mayan medicinal plants for treatment of
dysentery, gastritis, gastric ulcers, and other intestinal problems. In 2002, Ankli et al. [49]
confirmed that six species have activity against G. lamblia with IC50 values less than 100 µg/ml,
three of them with minimum inhibitory concentration (MIC) values less than 100 µg/ml. The
most active extract was the nonpolar extract A of Crossopetalum gaumeri (MIC = 6.3 µg/ml),
whereas the polar extract B showed a very weak antiprotozoal activity. The nonpolar and polar
extracts of Psidium sartorianum, Piscidia piscipula, Bidens squarrosa and Casimiroa tetrameria and the
nonpolar fraction of Bauhinia divaricata showed weak activity with IC50 values between 20 and
90 µg/ml. Later, Peraza-Sánchez et al. [93] demonstrated the in vitro antigiardial activity of
another set of 10 native plants from Yucatan, Mexico: Byrsonima crassifolia (L.) Kunth, Cupania
dentataDC.,Diphysa carthagenensis Jacq.,Dorstenia contrajerva L., Gliricidia sepium (Jacq.) Kunth ex
Walp., Justicia spicigera Schldl., Pluchea odorata (L.) Cass., Spigelia anthelmia L., Tridax procumbens
L., and Triumfetta semitriloba Jacq. The extract obtained from T. procumbens was the most active
(IC50 = 6.34 µg/ml), followed by C. dentata (IC50 = 7.59 µg/ml), D. carthagenensis (IC50 = 11.53
µg/ml), and B. crassifolia (IC50 = 15.55 µg/ml). G. sepium, J. spicigera, P. odorata, S. anthelmia, and
T. semitriloba were active in the range from 46.41 to 117.41 µg/ml. Hippocratea excelsa is another
Mayan medicinal plant with a confirmed anti-Giardia activity. From the different triterpenoids
that have been isolated from the root bark ofH. excelsa, pristimerine and tingenone were themost
active compounds with IC50 values of 0.11 and 0.74 µM, respectively [94].
Barbosa et al. [95] isolated the flavonoids kaempferol, tiliroside and ()-epicatechin from
G. mexicanum, Cuphea pinetorum, Helianthemum glomeratum, and Rubus coriifolius, which are
medicinal plants used for the treatment of gastrointestinal disorders in Mexico, and evaluated
their antiprotozoal activity in suckling females CD-1 mice infected with G. lamblia. The most
active flavonoid was ()-epicatechin (ED50 = 0.072 µmol/kg); its activity was even stronger
than that of metronidazole and emetine used as reference drugs. In the case of kaempferol and
tiliroside, their potency was close to that of metronidazole, but far less than emetine
(ED50=2.057 and 1.429 µmol/kg, respectively).
C. dentata (Sapindaceae family) is traditionally used against inflammation in Veracruz, Mexico
and pain in Quintana Roo, Mexico. Hernández-Chávez et al. [96] showed that methanolic,
hexanic, dichloromethane, ethyl acetate and butanolic extracts of C. dentata are able to inhibit
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the proliferation of Giardia trophozoites (IC50 = 8.17, 4.42, 2.12, 9.52 and 6.5 µg/ml, respec-
tively). The phytochemical study of fractions resulted in the isolation of taraxerone, taraxerol,
scopoletin, and two mixtures of steroidal compounds. Among them, taraxerone was the
metabolite with the highest giardicidal activity (IC50 = 11.33 μg/ml).
6. Mexican medicinal plants against Trichomonas vaginalis
6.1. Trichomonas vaginalis and trichomoniasis
T. vaginalis is an anaerobic flagellated protozoan that lives and replicates by binary fission in the
urogenital tract of humans, namely vulva, vagina, or urethra, in women, and urethra, prostate
and epididymis in men. The “pear” shaped trophozoite (10–20 μm in length) is the unique
morphological stage for this monoxen parasite for which human is the only host. Trichomonia-
sis represents the most prevalent nonviral sexually transmitted infection in the world, affecting
around 250 million people annually [97]. In Mexico, a recent report revealed that trichomoniasis
is at the 12th place among the 20 principal causes of infectious diseases with a rate of 104.23
cases per 100,000 individuals. Women are more affected than men at a ratio of 36:1 and women
aged 25–44 years represent the mayor number of cases (almost 60,000 infected women in 2011)
[98]. At least 50% of infected individuals are asymptomatic; they are neither detected nor
treated, which makes trichomoniasis a neglected parasitic infection that can silently spread
worldwide [99]. Symptomatic women develop vaginitis, cervicitis, urethritis, a malodourous
seropurulent vaginal discharge and infertility. Moreover, Trichomonas infection has been linked
to bad pregnancy outcomes (preterm birth, low birth weight, and respiratory infections in the
newborn). Importantly, trichomoniasis is an enhanced risk factor of getting or spreading other
sexually transmitted infections, such as human immunodeficiency virus (HIV), papilloma virus
(HPV) and herpes simplex virus II (HSV-2) [100–102]. Men usually represent the short-term
reservoir of T. vaginalis, but they may also suffer from urethritis [103]. In addition, an association
with worse prostate cancer prognosis has been reported [104].
Since the early 60s, the drug of choice for treating trichomoniasis is metronidazole and its
derivatives (tinidazole and secnidazole) [105]. As in the case of other anaerobic protozoan
pathogens, important side effects have been reported, including headache, nausea, gastroin-
testinal disturbance, and anorexia, as well as cytotoxic effects, which limit the efficacy of the
treatment [106, 107]. However, the main cause of treatment failure is the resistance of parasite
to 5-nitroimidazole derivatives. MTZ resistance has been observed in 5–20% of patients [108]
and around 10% of clinical isolates are 5-nitroimidazoles resistant in vitro [109]. In this context,
new treatments for trichomoniasis are necessary.
6.2. Relevant studies about Mexican plant with activity against Trichomonas vaginalis
With the purpose of searching for new drugs for the control of trichomoniasis, several groups
performed in vitro susceptibility assays to identify the anti-Trichomonas activity of Mexican
plants that were selected on the basis of chemotaxonomical criteria, as well as ethnobotanical
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and ethnopharmacological uses for the treatment of clinical signs associated with trichomoni-
asis, such as abdominal pain, colic, and vaginal discharge (Table 1).
In 2007, Calzada et al. [110] reported the antitrichomonal effect of methanol extracts of Carica
papaya and Cocos nucifera (IC50 values of 5.6 and 5.8 µg/ml, respectively), as well as Bocconia
frutescens, G. mexicanum, and Lygodium venustum (IC50 values ranging from 30.9 to 60.9 µg/ml)
collected in six states of the country, namely Mexico City, State of Mexico, Hidalgo, Guana-
juato, Sinaloa, and Yucatan, Mexico. The genotoxicity of the sanguinarine alkaloid present in
B. frutescens could explain the antiprotozoal activity of the extract.
In another study, Moo-Puc et al. [111] evaluated dichloromethane:methanol extracts of 25
tropical seaweeds (12 Rhodophyta, 5 Phaeophyta, and 8 Chlorophyta) from the coast of Gulf of
Mexico and Caribbean in Yucatan, Mexico. The most active algal extracts were from Lobophora
variegata (Phaeophyta) and Udotea conglutinata (Chlorophyta), with IC50 values of 1.3  0.7 and
1.6  0.1 µg/ml, respectively. Although their investigation did not involve structure elucida-
tion, the authors suggested that this effect could be due to the presence of terpenes and poly-
phenols that are known antiprotozoal compounds [112]. Interestingly, extracts were not toxic
for Madin-Darby canine kidney (MDCK) cells. The further characterization of the brown alga
L. variegata revealed its antioxidant activity [113]. Fractionation using different solvents and
isolation of antiprotozoal constituents indicated that the chloroformic fraction was the most
effective against T. vaginalis due to the presence of sulfoquinovosyl-diacylglycerols 1–3
(SQDGs 1–3) according to chromatographic fractionation on Sephadex LH-20, chemical and
enzymatic hydrolysis, as well as analysis of fast atom-mass spectrometry (FAB-MS) and NMR
spectroscopic data. The mixture of SQDGs 1–3 only had a moderate activity against T. vaginalis
trophozoites (IC50 = 8 μg/ml), being less effective than the whole extract. The authors con-
cluded that crude extract and nonpolar fractions from L. variegate, mainly the ethyl acetate
fraction, should contain the major inhibitory compounds [114].
In addition to their hypolipemic [115] and hypoglycemic [116] effects in animal models, extract
obtained from P. americana seeds has activity against several fungi [117], bacteria [118], and
protozoan parasites [90]. Notably, Jiménez-Arellanes et al. [119] showed that chloroformic and
ethanolic extracts of P. americana seeds obtained from the town of Ario de Rosales in the state of
Michoacan, Mexico, displayed significant activity against T. vaginalis (IC50 = 0.524 and 0.533
μg/ml, respectively). According to a preliminary analysis, these extracts contain β-sitosterol,
phytol and palmitic acid, and catechin and epicatechin, respectively, which could be responsi-
ble for the antiprotozoal activity.
7. Conclusion
It is clear that antiparasitic drugs currently available have been essential to control, at least
partially, the spread and illnesses related to malaria, trypanosomiasis, leishmaniasis, amoebia-
sis, giardiasis, and trichomoniasis. However, besides the existence of this chemotherapeutic
arsenal, these infections still represent a huge threat for human health worldwide, particularly
in developing countries. Failure in parasite elimination is mainly due to drug toxicity and
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emergence of drug resistance in both parasites and vectors. Thus, one of the main contempo-
rary challenges in global health is to find new, efficient and safe alternatives to prevent the
establishment of drug resistance strains. Mexican medicinal plants are recognized as important
sources of therapeutic compounds. Particularly, the present review supports the popular uses
of plants from different regions of Mexico for the treatment of some of the most prevalent
parasitic infections (Figure 1). In addition, it clearly highlights their potential for the isolation
and identification of new antiparasitic molecules. Unfortunately, it is worth noting that most
extracts, fractions, or isolated molecules tested were less or as efficient as the drug of choice for
each pathogen. This could be resolved by chemical modifications of the initial structure to
improve the stability of the molecule and its antiparasitic activity. The identification of the
biochemical targets could also allow the design of more active molecules through bioinformat-
ics screening and docking studies. On the other hand, prospective studies aimed to improve
delivery systems in vivo should help to circumvent the drawbacks related to stability, bioavail-
ability, and integrity of natural compounds. Some of these techniques currently used with
phytochemicals include nano- and microencapsulation in polymers of natural or synthetic
origin, or lipids. Another important point is the necessity of toxicity and mutagenicity tests to
confirm the safety of the most promising molecules.
Abbreviations
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FAB-MS Fast atom bombardment-mass spectrometry
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IC50 Half maximal inhibitory concentration
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MC100 Concentration inducing 100% of the maximum response
ME Methanol extract
MeOHe Methanolic extract
MFQ Mefloquine
MIC Minimum inhibitory concentration
MTZ Metronidazole
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